| XMD17 109 |
XMD17 109 |
1435488-37-1 |
| ARN-509 |
阿帕鲁胺 |
956104-40-8 |
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
| Ibrutinib |
依鲁替尼 |
936563-96-1 |
| 5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine |
5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺 |
935666-88-9 |
| GSK1014802 |
GSK1014802 |
934240-30-9 |
| 3-Ethynylimidazo[1,2-b]pyridazine |
3-炔基咪唑[1,2-B]哒嗪 |
943320-61-4 |
| Methyl 2,4-diaMino-3-fluoro-5-
nitrobenzoate |
2,4-二氨基-3-氟-5-硝基苯甲酸甲酯 |
918321-18-3 |
| PaloMid 529 (P529) |
PALOMID 529 (P529) |
914913-88-5 |
| 5'-fluoro-2'-Iodoacetophenone |
1-(5-氟-2-碘苯基)乙酮 |
914225-70-0 |
| indoleaMine-2,3-dioxygenase inhibitor INCB024360 |
4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 |
914471-09-3 |
| (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one.HCl |
利伐沙班中间体 |
898543-06-1 |
| (E)-3-[2-(Pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-amine |
(E)-3-[2-(吡啶-2-基)乙烯基]-1-(四氢-2H-吡喃-2-基)-1H-吲唑-6-胺 |
886230-76-8 |
| 3-Iodo-6-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole |
3-碘-6-硝基-1-(四氢-2H-吡喃-2-基)-1H-吲唑 |
886230-74-6 |
| (E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole |
(E)-6-碘-3-[2-(吡啶-2-基)乙烯基]-1-(四氢-2H-吡喃-2-基)-1H-吲唑 |
886230-77-9 |
| 2,2,2-trifluoro-1-(4'-(Methylsulfonyl)biphenyl-4-yl)ethanone |
ODANACATIB中间体 |
893407-18-6 |
| 4-chloro-3-(pyridin-2-yl)aniline |
4-氯-3-(2-吡啶基)苯胺 |
879088-41-2 |
| 5-Thiazolecarboxaldehyde, 2-cyclopropyl- |
2-环丙基噻唑-5-甲醛 |
877385-86-9 |
| 4-(4-Bromopyrazol-1-yl)piperidine-1-carboxylic acid tert-butyl ester |
4-(4-溴吡唑-1-基)哌啶-1-甲酸叔丁酯 |
877399-50-3 |
| 2-Fluoro-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzonitrile |
4-氰基-3-氟苯基硼酸频哪醇酯 |
870238-67-8 |
